Relpax
Product Images NDC 16590-201

5 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Relpax (NDC 16590-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Relpax 40 mg 16590 Label Image (Relpax 40 mg 16590 Label)

Relpax 40 mg 16590 Label Image (Relpax 40 mg 16590 Label)
Relpax 40 mg tablet packaging label by STAT Rx USA LLC, distributed by Pfizer Inc. The label shows 6 tablets per package with Eletriptan Hydrobromide equivalent to 40 mg per tablet. It includes prescription only warning and storage instructions, along with lot and sample information.*
FDA Label Image

Chemical Structure (Relpax 01)

Chemical Structure (Relpax 01)
Chemical structure of the active ingredient in Relpax, labeled with a hydrobromide (HBr) group. The diagram shows a complex arrangement of rings, sulfonyl, and methyl groups consistent with a pharmaceutical compound structure.*
FDA Label Image

Figure 1 (Relpax 02)

Figure 1 (Relpax 02)
A line graph titled 'Estimated Probability of Initial Headache Response Within 2 Hours' displaying the estimated probability of headache response on the y-axis and time from initial dose in hours on the x-axis. The graph compares response probabilities over 0 to 2 hours for double blind placebo and three doses of eletriptan (20 mg, 40 mg, 80 mg) using distinct line styles and markers.*
FDA Label Image

Figure 2 (Relpax 03)

Figure 2 (Relpax 03)
A line graph showing the estimated probability of taking a second dose or other medication over 24 hours after the first dose. The x-axis represents time from initial dose in hours, and the y-axis represents the probability of a second dose or other medication. Four lines compare double blind placebo and eletriptan at 20 mg, 40 mg, and 80 mg doses.*
FDA Label Image

Logo (Relpax 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.